» Articles » PMID: 37036837

Proteogenomic Analysis of Serratia Marcescens Using Computational Subtractive Genomics Approach

Overview
Journal PLoS One
Date 2023 Apr 10
PMID 37036837
Authors
Affiliations
Soon will be listed here.
Abstract

Serratia marcescens, a Gram-negative bacterium (Enterobacteriaceae) is a hospital-acquired opportunistic pathogen that infects the urinary and central nervous systems. The identification of new therapeutics against S. marcescens is crucial since it is now multi-drug resistant. Therefore, the current study was aimed to identify potential drug targets against S. marcescens strains i.e. WW4, SM39, and Db11 using comparative metabolic pathway analysis and subtractive genomics approach. The applied bioinformatics-based method was used to identify the unique metabolic pathways as the prioritized drug targets. The downstream analysis has led to the identification of three pathways that are specifically absent and/or present in the specific strain. Consequently, six proteins were identified through subtractive genomic analysis. The identified proteins were found as non-homologous and essential to the pathogen's survival as well as unique to the WW4 strain. The estimated features proposed it as a potential drug target. The selected protein was further subjected to in-depth structural analysis for the structure modeling, structure validation, and protein-protein interaction analysis. Furthermore, the library of ~1500 approved compounds was screened against selected drug target to identify potential drug candidates. The current work may help in repurposing of the drug compounds as novel medication against S. marcescens.

References
1.
Kim D, Chivian D, Baker D . Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004; 32(Web Server issue):W526-31. PMC: 441606. DOI: 10.1093/nar/gkh468. View

2.
cepl J, Blahuskova A, Cvrckova F, Markos A . Ammonia produced by bacterial colonies promotes growth of ampicillin-sensitive Serratia sp. by means of antibiotic inactivation. FEMS Microbiol Lett. 2014; 354(2):126-32. DOI: 10.1111/1574-6968.12442. View

3.
Cristina M, Sartini M, Spagnolo A . Infections in Neonatal Intensive Care Units (NICUs). Int J Environ Res Public Health. 2019; 16(4). PMC: 6406414. DOI: 10.3390/ijerph16040610. View

4.
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K . KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016; 45(D1):D353-D361. PMC: 5210567. DOI: 10.1093/nar/gkw1092. View

5.
Giri A, Anandkumar N, Muthukumaran G, Pennathur G . A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soil. BMC Microbiol. 2004; 4:11. PMC: 404375. DOI: 10.1186/1471-2180-4-11. View